Presented by Hydzik
Cardiovascular disease remains the leading cause of death worldwide, yet standard lipid panels and fasting glucose often miss patients already progressing toward atherosclerosis and insulin resistance. In this lecture, Heather Hydzik, ND, reviews the updated 2026 ACC/AHA guidelines and explains why LDL alone no longer suffices, pointing instead to markers like apolipoprotein B, lipoprotein(a), hsCRP, and adipokines. Through patient cases, she demonstrates how the Doctor's Data Cardiometabolic Profile reveals particle burden, inflammation, insulin resistance, and genetic risk that routine testing overlooks. Viewers will learn to interpret these advanced biomarkers and build personalized plans spanning nutrition, lifestyle, supplementation, and medication.